Stock deal locks funds for Scythian marijuana study
By GREGORY ZELLER // A Canadian R&D firm with Long Island roots has locked up the first tranche of a strategic investment that will fund a major study involving concussions…
Biotech
Northwell, drug-maker ink bioelectronics partnership
By GREGORY ZELLER // Bioelectronic medicine has taken another forward leap, thanks to the Feinstein Institute for Medical Research’s latest professional alliance. The research-and-development arm of the Northwell Health system…
Rockefeller researcher nabs Feinstein’s molecular prize
Advanced molecular-genetics studies have earned a Rockefeller University researcher accolades from the Feinstein Institute for Medical Research, and a fat check. While Feinstein Institute scientists are often the ones collecting…
Fighting forced labor, Applied DNA forms cotton club
By GREGORY ZELLER // So, where does your cotton come from? Applied DNA Sciences would like you to know. Adding to its portfolio of crimefighting products and services, the Stony…
Scythian, U of M concussion study hits the jack-pot
By GREGORY ZELLER // A Calgary-based R&D firm with strong Long Island ties has swung an eight-figure financing deal, lighting up a major study pitting cannabinoids against concussions. Scythian Biosciences…
GE brings good things to bioelectronics research
By GREGORY ZELLER // General Electric is giving the Feinstein Institute for Medical Research a bioelectronic jolt. The Feinstein Institute, R&D mecca of the Northwell Health system, announced a new…
New patent, new partnership for soaring Traverse
By GREGORY ZELLER // When a new U.S. patent is your second-biggest announcement of the day, you’re probably in a good place. It’s all smiles (with healthy teeth, of course)…
Codagenix: Flu can mutate, but it can’t hide
By GREGORY ZELLER // In a potentially huge breakthrough in the struggle against seasonal influenza mutations, Codagenix Inc. is preparing to release data demonstrating “multi-season efficacy” for its frontline flu…
Still cutting its teeth, Traverse set for stellar 2017
By GREGORY ZELLER // First, healthy teeth for dogs … then a cancer cure for the world? Financially and otherwise, Traverse Biosciences enjoyed a strong 2016 – but it may…
Tackling concussions with cannabis
By GREGORY ZELLER // A research effort stretching from Florida to Long Island to Canada’s Alberta province will determine if compounds derived from marijuana can be effective treatments for concussions. Calgary-based R&D…
Codagenix, SUNY RF ink exclusive licensing deal
A year of big steps has led to one giant leap for Codagenix. Stony Brook University, through the Research Foundation for the State University of New York, has entered into…
In Brazil, a big forward step for Chembio
The national health-regulatory agency of Brazil has approved commercial use of Chembio Diagnostics’ rapid field rest for the Zika virus – a major step toward selling the product in the…
Codagenix commences Zika vaccine testing
By GREGORY ZELLER // Farmingdale biotech Codagenix Inc. has commenced the first tests of its potential Zika virus vaccines in a living host. In a noteworthy display of speed sure to…
Chembio lands $13.2M Zika contract
Medford-based Chembio Diagnostics has won a $13.2 million federal contract to further develop its rapid test for the Zika virus, the company announced Thursday. Almost $6 million of the money –…
Feinstein researchers nab major NIH awards
Two cutting-edge Feinstein Institute for Medical Research projects have been selected for an elite National Institutes of Health funding program. Kevin Tracey, the institute’s president and CEO, and Ping Wang,…